(Q36808862)

English

HLA-DRB10401 and HLA-DRB10408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis

scientific article published on 24 July 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

Peter F. Stadler

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jörg Hackermüller

object named as

Jörg Hackermüller

5

0 references

Hans-Peter Hartung

7

object named as

Hans-Peter Hartung

1 reference

Europe PubMed Central

16 August 2017

PMC publication ID

author name string

Steve Hoffmann

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sabine Cepok

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Verena Grummel

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Klaus Lehmann-Horn

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Achim Berthele

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Florian Deisenhammer

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ralf Wassmuth

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Bernhard Hemmer

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

24 July 2008

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

American Journal of Human Genetics

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

83

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

219-227

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

The inheritance of resistance alleles in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Risk alleles for multiple sclerosis identified by a genomewide study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

TCR recognition of peptide/MHC class II complexes and superantigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Immunogenicity of therapeutic proteins. Part 3: impact of manufacturing changes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

The genetic basis of autoantibody production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

MHC class II proteins and disease: a structural perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Integrated analysis of genetic data with R.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Follicular B helper T cells in antibody responses and autoimmunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Factors influencing the immunogenicity of therapeutic proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

When biotech proteins go off-patent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Immunogenicity of interferon beta: differences among products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Immunogenicity of therapeutic proteins: clinical implications and future prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Bioequivalence and the immunogenicity of biopharmaceuticals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Score tests for association between traits and haplotypes when linkage phase is ambiguous

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Multiple sclerosis: genomic rewards

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

29 September 2017

The genetic analysis of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

27 June 2018

Rapid HLA-DRB1 genotyping by nested PCR amplification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

27 June 2018

MxA Gene Expression Analysis as an Interferon-β Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

5 September 2018

Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

5 September 2018

Genetics of multiple sclerosis

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

20 October 2018

https://pubmed.ncbi.nlm.nih.gov/18656179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2495071

4 December 2018

Approval of new biopharmaceuticals 1999-2006: comparison of the US, EU and Japan situations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18656179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of SARS with human interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/18656179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18656179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improved ELISA for screening for neutralizing anti-IFN-beta antibodies in MS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18656179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/18656179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.AJHG.2008.07.006

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36808862&oldid=1657318445"